title: Tacrolimus is effective in both dual and triple regimens after liver transplantation.
authors.affiliation: Hospital Virgen del Rocío, Seville, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Serrano
authors.forename: M
authors.initials: M
authors.lastname: García González
authors.forename: M
authors.initials: M
authors.lastname: Gómez
authors.forename: J
authors.initials: J
authors.lastname: Ortiz de Urbina
authors.forename: P
authors.initials: P
authors.lastname: López Cillero
authors.forename: F
authors.initials: F
authors.lastname: San Juan
authors.forename: P
authors.initials: P
authors.lastname: Parrilla
authors.forename: J I
authors.initials: JI
authors.lastname: Herrero
mesh_terms: D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000453:epidemiology; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus